Table 1.
Clinical characteristics of Vaspin Low group subjects
| Men | Women | |
|---|---|---|
| Number of subjects | 74 | 67 |
| Age (year) | 45.4 ± 17.6 | 43.2 ± 18.0 |
| Height (cm) | 170.9 ± 6.0 | 158.2 ± 6.6 |
| Body weight (kg) | 66.6 ± 9.7 | 52.5 ± 7.3 |
| Body mass index (kg/m2) | 22.8 ± 3.0 | 21.0 ± 3.0 |
| Abdominal circumference (cm) | 80.8 ± 8.0 | 76.2 ± 9.5 |
| Body fat percentage (%) | 19.4 ± 6.0 | 27.4 ± 6.1 |
| Peak oxygen uptake (mL/kg/min) | 37.2 ± 9.3 | 30.5 ± 7.9 |
| Physical activity (METs⋅h/w) | 13.2 ± 8.5 | 13.6 ± 10.5 |
| Systolic blood pressure (mmHg) | 133.2 ± 15.7 | 122.8 ± 16.8 |
| Diastolic blood pressure (mmHg) | 82.9 ± 12.0 | 75.0 ± 11.9 |
| Blood profile | ||
| Vaspin (ng/mL) | 0.12 ± 0.18 | 0.39 ± 0.70 |
| Triglyceride (mg/dL) | 98.4 ± 59.2 | 72.5 ± 48.4 |
| HDL cholesterol (mg/dL) | 55.4 ± 13.9 | 67.4 ± 14.1 |
| Blood glucose (mg/dL) | 93.1 ± 9.6 | 88.4 ± 9.0 |
| Number of subjects with smoking habits (%) | 33 (44.6 %) | 4 (6.0 %) |
Mean ± SD
METs⋅h/w: Σ [metabolic equivalents × h per week (METs⋅h/w)]